Edition:
United States

Lonza Group AG (LONN.S)

LONN.S on Virt-X Level 1

310.50CHF
17 Aug 2018
Change (% chg)

CHF-1.00 (-0.32%)
Prev Close
CHF311.50
Open
CHF313.20
Day's High
CHF313.20
Day's Low
CHF309.90
Volume
275,301
Avg. Vol
314,728
52-wk High
CHF321.00
52-wk Low
CHF218.00

Chart for

About

Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The Life Science Ingredients division comprises a... (more)

Overall

Beta: 1.11
Market Cap(Mil.): CHF23,122.55
Shares Outstanding(Mil.): 74.47
Dividend: 2.75
Yield (%): 0.89

Financials

  LONN.S Industry Sector
P/E (TTM): 26.01 95.67 30.17
EPS (TTM): 11.94 -- --
ROI: 9.33 3.33 12.67
ROE: 15.36 2.31 14.86

BRIEF-Lonza Group AG Expands Its Distribution Relationship With Azelis Americas

* SAYS LONZA CONSUMER PRODUCT INGREDIENTS EXPANDS ITS DISTRIBUTION RELATIONSHIP WITH AZELIS AMERICAS

Jul 16 2018

UPDATE 1-Lonza confirms targets as gets off to good start

ZURICH, May 4 Swiss drug ingredients maker Lonza confirmed its guidance on Friday and said it had got off to a good start this year.

May 04 2018

Lonza confirms targets as Q1 gets off to good start

ZURICH, May 4 Swiss drug ingredients maker Lonza confirmed its guidance on Friday and said it had got off to a good start this year.

May 04 2018

Samsung BioLogics' shares slide again; unit's valuation jump questioned

SEOUL Shares in South Korea's Samsung BioLogics Co Ltd fell 3.5 percent on Thursday, a day after losing almost $6 billion in market value as the contract biotech drugmaker was hit by a regulatory probe into its accounting rules.

May 03 2018

Samsung BioLogics' shares slide again; unit's valuation jump questioned

SEOUL, May 3 Shares in South Korea's Samsung BioLogics Co Ltd fell 3.5 percent on Thursday, a day after losing almost $6 billion in market value as the contract biotech drugmaker was hit by a regulatory probe into its accounting rules.

May 03 2018

UPDATE 3-Accounting concerns wipe $6 bln off Samsung BioLogics market value

* Financial watchdog gives preliminary notice to co on measures

May 02 2018

Lonza's virus factory shows gene therapy's Texas-sized promise

ZURICH Swiss drugmaker-for-hire Lonza is betting that trillions of customized viruses made at a giant factory in Texas will be the lucrative raw materials of a medical revolution.

Apr 10 2018

FOCUS-Lonza's virus factory shows gene therapy's Texas-sized promise

ZURICH, April 10 Swiss drugmaker-for-hire Lonza is betting that trillions of customized viruses made at a giant factory in Texas will be the lucrative raw materials of a medical revolution.

Apr 10 2018

Earnings vs. Estimates